Italy
· Delayed Price · Currency is EUR Philogen Statistics
Total Valuation
Philogen has a market cap or net worth of EUR 846.08 million. The enterprise value is 785.65 million.
| Market Cap | 846.08M |
| Enterprise Value | 785.65M |
Important Dates
The next estimated earnings date is Wednesday, September 25, 2024.
| Earnings Date | Sep 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Philogen has 40.29 million shares outstanding. The number of shares has decreased by -2.31% in one year.
| Shares Outstanding | 40.29M |
| Shares Change (YoY) | -2.31% |
| Shares Change (QoQ) | -0.53% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 4.20% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 20.39 |
| PS Ratio | 34.18 |
| PB Ratio | 9.34 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -127.52 |
| EV / Sales | 31.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -75.77 |
Financial Position
The company has a current ratio of 7.02, with a Debt / Equity ratio of 16.46.
| Current Ratio | 7.02 |
| Quick Ratio | 6.82 |
| Debt / Equity | 16.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.44 |
| Interest Coverage | -18.83 |
Financial Efficiency
Return on equity (ROE) is -6.54% and return on invested capital (ROIC) is -5.30%.
| Return on Equity (ROE) | -6.54% |
| Return on Assets (ROA) | -4.74% |
| Return on Capital (ROIC) | -5.30% |
| Revenue Per Employee | 149,885 |
| Profits Per Employee | -37,339 |
| Employee Count | 165 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 8.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.68% in the last 52 weeks. The beta is 0.19, so Philogen's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +25.68% |
| 50-Day Moving Average | 21.03 |
| 200-Day Moving Average | 18.89 |
| Relative Strength Index (RSI) | 39.09 |
| Average Volume (20 Days) | 4,044 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Philogen had revenue of EUR 24.73 million and -6.16 million in losses. Loss per share was -0.15.
| Revenue | 24.73M |
| Gross Profit | 7.27M |
| Operating Income | -9.29M |
| Pretax Income | -6.18M |
| Net Income | -6.16M |
| EBITDA | -6.61M |
| EBIT | -9.29M |
| Loss Per Share | -0.15 |
Balance Sheet
The company has 75.34 million in cash and 14.92 million in debt, giving a net cash position of 60.43 million or 1.50 per share.
| Cash & Cash Equivalents | 75.34M |
| Total Debt | 14.92M |
| Net Cash | 60.43M |
| Net Cash Per Share | 1.50 |
| Equity (Book Value) | 90.59M |
| Book Value Per Share | 2.25 |
| Working Capital | 76.53M |
Cash Flow
In the last 12 months, operating cash flow was -4.82 million and capital expenditures -5.55 million, giving a free cash flow of -10.37 million.
| Operating Cash Flow | -4.82M |
| Capital Expenditures | -5.55M |
| Free Cash Flow | -10.37M |
| FCF Per Share | -0.26 |
Margins
Gross margin is 29.39%, with operating and profit margins of -37.54% and -24.91%.
| Gross Margin | 29.39% |
| Operating Margin | -37.54% |
| Pretax Margin | -24.99% |
| Profit Margin | -24.91% |
| EBITDA Margin | -26.72% |
| EBIT Margin | -37.54% |
| FCF Margin | -41.93% |
Dividends & Yields
Philogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.31% |
| Shareholder Yield | 2.31% |
| Earnings Yield | -0.73% |
| FCF Yield | -1.23% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |